LexDanaLexDanabeta
Inventor

JAMES DODGE

Inventor
US

Overview

3→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C12NMicroorganisms or enzymes27%
C07KPeptides9%
C12YEnzymes9%
PatentTitleYear
11,957,765Gene therapy for neurometabolic disorders202411,554,161Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders202311,369,693Gene therapy for lysosomal storage diseases2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to GENZYME CORP (3)· patent assignee history
2022–2024Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GENZYME CORP32022–2024
Locations
LocationPatentsSpan
US32022–2024